Herbert D. Kleber - Publications

Affiliations: 
1997- Psychiatry Columbia University College of Physicians and Surgeons, New York, NY, United States 

199 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Degroot A, Edwards RR, Haddox JD, Jaffe JH, Jones CM, Kleber HD, Kopecky EA, Markman JD, Montoya ID, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 154: 2287-96. PMID 23792283 DOI: 10.1016/j.pain.2013.05.053  0.36
2012 Kleber HD, DuPont RL. Physicians and medical marijuana. The American Journal of Psychiatry. 169: 564-8. PMID 22684592 DOI: 10.1176/appi.ajp.2012.12030373  0.36
2012 Kleber HD, Dupont RL. Response to Grant et al. Letter American Journal of Psychiatry. 169: 1120. DOI: 10.1176/appi.ajp.2012.12060791r  0.36
2011 Gunderson EW, Levin FR, Rombone MM, Vosburg SK, Kleber HD. Improving temporal efficiency of outpatient buprenorphine induction. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 20: 397-404. PMID 21838837 DOI: 10.1111/j.1521-0391.2011.00153.x  0.36
2011 Martinez D, Carpenter KM, Liu F, Slifstein M, Broft A, Friedman AC, Kumar D, Van Heertum R, Kleber HD, Nunes E. Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. The American Journal of Psychiatry. 168: 634-41. PMID 21406463 DOI: 10.1176/appi.ajp.2010.10050748  0.36
2010 Comer SD, Sullivan MA, Vosburg SK, Manubay J, Amass L, Cooper ZD, Saccone P, Kleber HD. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction (Abingdon, England). 105: 709-18. PMID 20403021 DOI: 10.1111/j.1360-0443.2009.02843.x  0.36
2010 Martinez D, Orlowska D, Narendran R, Slifstein M, Liu F, Kumar D, Broft A, Van Heertum R, Kleber HD. Dopamine type 2/3 receptor availability in the striatum and social status in human volunteers. Biological Psychiatry. 67: 275-8. PMID 19811777 DOI: 10.1016/j.biopsych.2009.07.037  0.36
2009 Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R, Slifstein M, Van Heertum R, Kleber HD. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. The American Journal of Psychiatry. 166: 1170-7. PMID 19723785 DOI: 10.1176/appi.ajp.2009.08121801  0.36
2009 Gerra G, Maremmani I, Capovani B, Somaini L, Berterame S, Tomas-Rossello J, Saenz E, Busse A, Kleber H. Long-acting opioid-agonists in the treatment of heroin addiction: Why should we call them substitution? Substance Use and Misuse. 44: 663-671. PMID 19360539 DOI: 10.1080/10826080902810251  0.36
2009 Martinez D, Slifstein M, Narendran R, Foltin RW, Broft A, Hwang DR, Perez A, Abi-Dargham A, Fischman MW, Kleber HD, Laruelle M. Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1774-82. PMID 19177067 DOI: 10.1038/npp.2008.235  0.36
2008 Kleber HD. Methadone maintenance 4 decades later: thousands of lives saved but still controversial. Jama. 300: 2303-5. PMID 19017918 DOI: 10.1001/jama.2008.648  0.36
2008 Yu E, Miotto K, Akerele E, O'Brien CP, Ling W, Kleber H, Fischman MW, Elkashef A, Herman BH, Al-Ghananeem AM. Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis. The American Journal of Drug and Alcohol Abuse. 34: 611-6. PMID 18821454 DOI: 10.1080/00952990802308122  0.36
2008 Yu E, Miotto K, Akerele E, Montgomery A, Elkashef A, Walsh R, Montoya I, Fischman MW, Collins J, McSherry F, Boardman K, Davies DK, O'Brien CP, Ling W, Kleber H, et al. A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal. Drug and Alcohol Dependence. 97: 158-68. PMID 18508207 DOI: 10.1016/j.drugalcdep.2008.04.002  0.36
2008 Smith MY, Kleber HD, Katz N, Houck LK, Sabo A. Reducing opioid. analgesic abuse: models for successful collaboration among government, industry and other key stakeholders. Drug and Alcohol Dependence. 95: 177-81. PMID 18484109 DOI: 10.1016/j.drugalcdep.2008.01.001  0.36
2008 Akerele E, Bisaga A, Sullivan MA, Garawi F, Comer SD, Thomas AA, Nunes EV, Kleber HD. Dextromethorphan and quinidine combination for heroin detoxification. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 176-80. PMID 18463993 DOI: 10.1080/10550490802019543  0.36
2008 Levin FR, Kleber HD. Use of dronabinol for cannabis dependence: two case reports and review. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 161-4. PMID 18393061 DOI: 10.1080/10550490701861177  0.36
2007 Kleber HD. Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues in Clinical Neuroscience. 9: 455-70. PMID 18286804  0.36
2007 Smith MY, Bailey JE, Woody GE, Kleber HD. Abuse of buprenorphine in the United States: 2003-2005. Journal of Addictive Diseases. 26: 107-11. PMID 18018814 DOI: 10.1300/J069v26n03_12  0.36
2007 Vorel SR, Bisaga A, McKhann G, Kleber HD. Insula damage and quitting smoking. Science (New York, N.Y.). 317: 318-9; author reply . PMID 17641181 DOI: 10.1126/science.317.5836.318c  0.36
2007 Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. The American Journal of Psychiatry. 164: 5-123. PMID 17569411  0.36
2007 Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, Huang Y, Cooper TB, Fischman MW, Kleber HD, Laruelle M. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. The American Journal of Psychiatry. 164: 622-9. PMID 17403976 DOI: 10.1176/appi.ajp.164.4.622  0.36
2007 Schottenfeld R, Carroll K, Kosten T, O'Malley S, Rounsaville B, Sinha R, Kleber H. Connecticut Mental Health Center: Clinical, Research and Training Programs in the Addictions 40 Years of Academic Public Psychiatry. 21-49. DOI: 10.1002/9780470994580.ch2  0.36
2007 Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP. In reply [2] Archives of General Psychiatry. 64: 865. DOI: 10.1001/jama.1990.03440150052019  0.36
2006 Gunderson EW, Fiellin DA, Levin FR, Sullivan LE, Kleber HD. Evaluation of a combined online and in person training in the use of buprenorphine. Substance Abuse. 27: 39-45. PMID 17135179 DOI: 10.1300/J465v27n03_06  0.36
2006 Nunes EV, Rothenberg JL, Sullivan MA, Carpenter KM, Kleber HD. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness? The American Journal of Drug and Alcohol Abuse. 32: 503-17. PMID 17127538 DOI: 10.1080/00952990600918973  0.36
2006 Kleber HD, Weiss RD, Anton RF, Rounsaville BJ, George TP, Strain EC, Greenfield SF, Ziedonis DM, Kosten TR, Hennessy G, O'Brien CP, Connery HS, McIntyre JS, et al. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. The American Journal of Psychiatry. 163: 5-82. PMID 16981488  0.36
2006 Miller JM, Vorel SR, Tranguch AJ, Kenny ET, Mazzoni P, van Gorp WG, Kleber HD. Anhedonia after a selective bilateral lesion of the globus pallidus. The American Journal of Psychiatry. 163: 786-8. PMID 16648316 DOI: 10.1176/appi.ajp.163.5.786  0.36
2006 Sullivan MA, Rothenberg JL, Vosburg SK, Church SH, Feldman SJ, Epstein EM, Kleber HD, Nunes EV. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 15: 150-9. PMID 16595353 DOI: 10.1080/10550490500528464  0.36
2006 Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Archives of General Psychiatry. 63: 210-8. PMID 16461865 DOI: 10.1001/archpsyc.63.2.210  0.36
2006 Collins SL, Levin FR, Foltin RW, Kleber HD, Evans SM. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug and Alcohol Dependence. 82: 158-67. PMID 16213109 DOI: 10.1016/j.drugalcdep.2005.09.003  0.36
2006 Kleber HD. Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. Psychopharmacology. 187: 291-292. DOI: 10.1007/s00213-006-0461-9  0.36
2006 Collins ED, Kleber HD, Whittington RA. In reply [3] Journal of the American Medical Association. 295: 886. DOI: 10.1001/jama.295.8.886-a  0.36
2006 Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, et al. Treatment of patients with substance use disorders: Second edition American Journal of Psychiatry. 163: 1-81.  0.36
2005 Kleber HD. Changing the battle plan. The Journal of Trauma. 59: S33-6. PMID 16355059 DOI: 10.1097/01.ta.0000174926.68892.1c  0.36
2005 Dart RC, Woody GE, Kleber HD. Prescribing methadone as an analgesic. Annals of Internal Medicine. 143: 620. PMID 16230741  0.36
2005 Collins ED, Kleber HD, Whittington RA, Heitler NE. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. Jama. 294: 903-13. PMID 16118380 DOI: 10.1001/jama.294.8.903  0.36
2005 Johnson PB, Richter L, Kleber HD, McLellan AT, Carise D. Telescoping of drinking-related behaviors: gender, racial/ethnic, and age comparisons. Substance Use & Misuse. 40: 1139-51. PMID 16040374 DOI: 10.1081/JA-200042281  0.36
2005 Kleber HD. Future advances in addiction treatment Clinical Neuroscience Research. 5: 201-205. DOI: 10.1016/j.cnr.2005.09.001  0.36
2004 Carise D, McLellan AT, Festinger DS, Kleber HD. Identifying United States substance abuse treatment programs: a test in one mid-sized city. Substance Abuse. 25: 21-8. PMID 15982964 DOI: 10.1300/J465v25n02_04  0.36
2004 Kleber HD. Treatment of drug dependence enters a new high technological era. Addiction (Abingdon, England). 99: 1476-7. PMID 15500602 DOI: 10.1111/j.1360-0443.2004.00901.x  0.36
2004 Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR. Consensus statement on office-based treatment of opioid dependence using buprenorphine. Journal of Substance Abuse Treatment. 27: 153-9. PMID 15450648 DOI: 10.1016/j.jsat.2004.06.005  0.36
2004 Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y, Perez A, Frankle WG, Cooper T, Kleber HD, Fischman MW, Laruelle M, Frankel WG. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1190-202. PMID 15010698 DOI: 10.1038/sj.npp.1300420  0.36
2003 McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public's demand for quality care? Journal of Substance Abuse Treatment. 25: 117-21. PMID 14680015 DOI: 10.1016/S0740-5472(03)00156-9  0.36
2003 Kleber HD. Pharmacologic treatments for heroin and cocaine dependence. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 12: S5-S18. PMID 12857659  0.36
2002 Akerele EO, Levin F, Nunes E, Brady R, Kleber H. Effects of HIV triple therapy on methadone levels American Journal On Addictions. 11: 308-314. PMID 12584873 DOI: 10.1080/1055049029008810  0.36
2002 Rothenberg JL, Sullivan MA, Church SH, Seracini A, Collins E, Kleber HD, Nunes EV. Behavioral naltrexone therapy: an integrated treatment for opiate dependence. Journal of Substance Abuse Treatment. 23: 351-60. PMID 12495797 DOI: 10.1016/S0740-5472(02)00301-X  0.36
2002 Johnson PB, Richter L, Carise D, McLellan AT, Kleber HD. Alcohol use patterns before and after September 11th. American Clinical Laboratory. 21: 25-7. PMID 12380027  0.36
2002 Kleber HD. The best should not be the enemy of the good. Addiction (Abingdon, England). 97: 660-1; discussion 66. PMID 12084133 DOI: 10.1046/j.1360-0443.2002.t01-5-00070.x  0.36
2002 Ginzburg V, Hart CL, Cheng TO, Frank BL, Kaptchuk TJ, Newman RG, Margolin A, Kleber H. Acupuncture for the treatment of cocaine addiction [2] (multiple letters) Journal of the American Medical Association. 287: 1800-1802. PMID 11939852  0.36
2002 Kleber HD. Marian Weinbaum Fischman, 1939-2001. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 557-60. PMID 11933910 DOI: 10.1016/S0893-133X(02)00297-X  0.36
2002 Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW. Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology. 159: 351-60. PMID 11823887 DOI: 10.1007/s002130100909  0.36
2002 Margolin A, Kleber HD, Avants SK, Konefal J, Gawin F, Stark E, Sorensen J, Midkiff E, Wells E, Jackson TR, Bullock M, Culliton PD, Boles S, Vaughan R. Acupuncture for the treatment of cocaine addiction: a randomized controlled trial. Jama. 287: 55-63. PMID 11754709  0.36
2002 Kleber HD, Naccari C. The ten interview. An interview with Herbert Kleber, MD Economics of Neuroscience. 4: 30-33.  0.36
2002 Kleber HD, Naccari C. Tackling a nation's addiction Economics of Neuroscience. 4: 17.  0.36
2001 Kleber H. Ibogaine: proceedings of the First International Conference The Alkaloids. Chemistry and Biology. 56: xv-xvii. PMID 11705119  0.36
2001 Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology. 157: 1-10. PMID 11512037 DOI: 10.1007/s002130100739  0.36
2001 Mark TL, Woody GE, Juday T, Kleber HD. The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence. 61: 195-206. PMID 11137285 DOI: 10.1016/S0376-8716(00)00162-9  0.36
2001 Amerson L, Lee Smith D, McLellan AT, O'Brien CP, Kleber HD, Lewis D. Drug depedence as a chronic medical illness [2] (multiple letters) Journal of the American Medical Association. 285: 409.  0.36
2000 Whittington RA, Collins ED, Kleber HD. Rapid opioid detoxification during general anesthesia: is death not a significant outcome? Anesthesiology. 93: 1363-4. PMID 11046233  0.36
2000 Johnson PB, Boles SM, Vaughan R, Kleber HD. The co-occurrence of smoking and binge drinking in adolescence. Addictive Behaviors. 25: 779-83. PMID 11023019 DOI: 10.1016/S0306-4603(99)00066-0  0.36
2000 McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. Jama. 284: 1689-95. PMID 11015800  0.36
2000 Johnson PB, Boles SM, Kleber HD. The relationship between adolescent smoking and drinking and likelihood estimates of illicit drug use. Journal of Addictive Diseases. 19: 75-81. PMID 10809521 DOI: 10.1300/J069v19n02_06  0.36
2000 Johnson PB, Boles SM, Kleber HD, Vaughan RD, McVeigh KH. Age-related differences in adolescent smokers' and nonsmokers' assessments of the relative addictiveness and health harmfulness of cigarettes, alcohol, and marijuana. Journal of Substance Abuse. 11: 45-52. PMID 10756513 DOI: 10.1016/S0899-3289(99)00019-X  0.36
1999 Merrill JC, Kleber HD, Shwartz M, Liu H, Lewis SR. Cigarettes, alcohol, marijuana, other risk behaviors, and American youth. Drug and Alcohol Dependence. 56: 205-12. PMID 10529022 DOI: 10.1016/S0376-8716(99)00034-4  0.36
1999 Levin FR, Evans SM, Kleber HD. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychiatric Services (Washington, D.C.). 50: 1001-3. PMID 10445644  0.36
1999 Carise D, McLellan AT, Gifford LS, Kleber HD. Developing a national addiction treatment information system. An introduction to the Drug Evaluation Network System. Journal of Substance Abuse Treatment. 17: 67-77. PMID 10435253 DOI: 10.1016/S0740-5472(98)00047-6  0.36
1999 Rosenthal MS, Kleber HD. Making sense of medical marijuana. Proceedings of the Association of American Physicians. 111: 159-65. PMID 10220811  0.36
1998 Kleber HD. Ultrarapid opiate detoxification. Addiction (Abingdon, England). 93: 1629-33. PMID 9926526 DOI: 10.1080/09652149834450  0.36
1998 Margolin A, Avants SK, Kleber HD. Rationale and design of the Cocaine Alternative Treatments Study (CATS): a randomized, controlled trial of acupuncture. Journal of Alternative and Complementary Medicine (New York, N.Y.). 4: 405-18. PMID 9884178  0.36
1998 Judd LL, Marston MG, Attkisson C, Berrettini W, Buc NL, Bunney BS, Murphy CBG, Dominguez RA, Friedel RO, Drummond HE, Gustafson JS, Hedeker D, Hiatt HH, Mostaghim R, Petersdorf RG, ... ... Kleber HD, et al. Effective medical treatment of opiate addiction Journal of the American Medical Association. 280: 1936-1943. PMID 9851480  0.36
1998 Margolin A, Avants SK, Kleber HD. Investigating alternative medicine therapies in randomized controlled trials. Jama. 280: 1626-8. PMID 9820270  0.36
1998 Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence. 52: 15-25. PMID 9788002 DOI: 10.1016/S0376-8716(98)00049-0  0.36
1998 Levin FR, Evans SM, Coomaraswammy S, Collins ED, Regent N, Kleber HD. Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study. The American Journal of Drug and Alcohol Abuse. 24: 343-60. PMID 9741939 DOI: 10.3109/00952999809016902  0.36
1998 Levin FR, Evans SM, McDowell DM, Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. The Journal of Clinical Psychiatry. 59: 300-5. PMID 9671342  0.36
1996 Margolin A, Avants SK, Birch S, Falk CX, Kleber HD. Methodological investigations for a multisite trial of auricular acupuncture for cocaine addiction: a study of active and control auricular zones. Journal of Substance Abuse Treatment. 13: 471-81. PMID 9219144 DOI: 10.1016/S0740-5472(96)00065-7  0.36
1996 Kleber HD. The Nathan B. Eddy Award Lecture: "A passion to improve treatment". Nida Research Monograph. 162: 24-33. PMID 9066805  0.36
1996 Kleber HD, Anton RF, Chick J, Croop R, O'Brien CP. Clinical applications of new alcoholism studies American Journal On Addictions. 5: S38-S44.  0.36
1995 Levin FR, Kleber HD. Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harvard Review of Psychiatry. 2: 246-58. PMID 9384909 DOI: 10.3109/10673229509017144  0.36
1995 Kleber HD, Tamminga CA, Schreur, Willner P, Piercey MF, Caron MG, Wise RA. Pharmacotherapy, current and potential, for the treatment of cocaine dependence Clinical Neuropharmacology. 18: S96-S109.  0.36
1995 Lahti RA, Lahti AC, Tamminga CA, Ranhosky, Kleber HD, Wise RA, Sethy. D2-family receptors in schizophrenia: Distribution and implications for treatment Clinical Neuropharmacology. 18: S110-S120.  0.36
1995 Kleber H, Weich R, Solarz A, Kleiman M. The relationship of science to drug abuse policy Nida Research Monograph Series. 33-36.  0.36
1994 Kleber HD. Our current approach to drug abuse--progress, problems, proposals. The New England Journal of Medicine. 330: 361-5. PMID 8277959 DOI: 10.1056/NEJM199402033300514  0.36
1994 Chilcoat HD, Schwartz RH, McCarthy JJ, Milman DH, Voth EA, DuPont RL, Grinspoon L, Bakalar JB, Kleber HD. The war on drugs [1] New England Journal of Medicine. 331: 126-129. PMID 8208255 DOI: 10.1056/NEJM199407143310213  0.36
1992 Kleber HD. Treatment of cocaine abuse: pharmacotherapy. Ciba Foundation Symposium. 166: 195-200; discussion . PMID 1638913  0.36
1992 Kosten TR, Morgan C, Kleber HD. Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone. Nida Research Monograph. 121: 101-19. PMID 1406906  0.36
1992 McDougle CJ, Price LH, Palumbo JM, Kosten TR, Heninger GR, Kleber HD. Dopaminergic responsivity during cocaine abstinence: a pilot study. Psychiatry Research. 43: 77-85. PMID 1359594 DOI: 10.1016/0165-1781(92)90143-Q  0.36
1991 Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. The American Journal of Psychiatry. 148: 1712-6. PMID 1957935  0.36
1991 Kleber HD. Tracking the cocaine epidemic. The Drug Abuse Warning Network. Jama. 266: 2272-3. PMID 1920728 DOI: 10.1001/jama.266.16.2272  0.36
1991 Kosten TR, Morgan C, Kleber HD. Treatment of heroin addicts using buprenorphine. The American Journal of Drug and Alcohol Abuse. 17: 119-28. PMID 1862786 DOI: 10.3109/00952999108992815  0.36
1990 Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD. Opioid antagonist challenges in buprenorphine maintained patients. Drug and Alcohol Dependence. 25: 73-8. PMID 2323312 DOI: 10.1016/0376-8716(90)90144-4  0.36
1990 Andersen M, Coleman SB, Ford W, Gorsuch RL, Kaplan H, Kleber H, Lief N, McAuliffe W, Shontz F, Weil A, Zinberg NE, Brown B, De Leon G, Glaser F, Huba G, et al. From theory to practice: The planned treatment of drug users International Journal of the Addictions. 25: 819-859. PMID 2272724 DOI: 10.3109/10826089009056208  0.36
1990 DuPont R, Jaffe J, Kleber H. Commentary: NIDA's role in applied research Nida Research Monograph. 100: 225-239. PMID 2132773  0.36
1990 Weil A. From theory to practice: the planned treatment of drug users. The International Journal of the Addictions. 25: 1099-125. PMID 2090637  0.36
1990 Kleber HD. The nosology of abuse and dependence. Journal of Psychiatric Research. 24: 57-64. PMID 1980700 DOI: 10.1016/0022-3956(90)90036-P  0.36
1990 Kashkin KB, Kleber HD. Hooked on hormones (Reply) Journal of the American Medical Association. 263: 2049. DOI: 10.1001/jama.263.15.2049  0.36
1989 Kosten TR, Kleber HD, Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sciences. 44: 887-92. PMID 2927249 DOI: 10.1016/0024-3205(89)90589-4  0.36
1989 Kosten TR, Kleber HD, Morgan C. Treatment of cocaine abuse with buprenorphine. Biological Psychiatry. 26: 637-9. PMID 2790101 DOI: 10.1016/0006-3223(89)90090-5  0.36
1989 Kleber HD. From theory to practice: the planned treatment of drug users. Interview by Stanley Einstein. The International Journal of the Addictions. 24: 123-66. PMID 2767823 DOI: 10.3109/10826088909047280  0.36
1989 Kashkin KB, Kleber HD. Hooked on hormones? An anabolic steroid addiction hypothesis. Jama. 262: 3166-70. PMID 2681859 DOI: 10.1001/jama.262.22.3166  0.36
1989 Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD. Rapid detoxification from opioid dependence. The American Journal of Psychiatry. 146: 1349. PMID 2675644  0.36
1989 Kosten TR, Morgan CJ, Kleber HD. Buprenorphine treatment of cocaine abuse. Nida Research Monograph. 95: 461. PMID 2641031  0.36
1989 Kleber HD. Drug abuse liability testing: human subject issues. Nida Research Monograph. 92: 341-56. PMID 2512500  0.36
1989 Gawin FH, Morgan C, Kosten TR, Kleber HD. Double-blind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology. 97: 402-3. PMID 2497490 DOI: 10.1007/BF00439458  0.36
1989 Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C. Desipramine facilitation of initial cocaine abstinence. Archives of General Psychiatry. 46: 117-21. PMID 2492422 DOI: 10.1001/archpsyc.1989.01810020019004  0.36
1989 Kleber HD. Treatment of drug dependence: What works International Review of Psychiatry. 1: 81-99. DOI: 10.3109/09540268909110386  0.36
1988 Vining E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. British Journal of Addiction. 83: 567-75. PMID 3382815  0.36
1988 Kosten TR, Rounsaville BJ, Kleber HD. Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up. The Journal of Nervous and Mental Disease. 176: 176-81. PMID 3343591  0.36
1988 Kosten TR, Kleber HD. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sciences. 42: 635-41. PMID 3276999 DOI: 10.1016/0024-3205(88)90454-7  0.36
1988 Kleber HD. Epidemic cocaine abuse: America's present, Britain's future? British Journal of Addiction. 83: 1359-71. PMID 3266086  0.36
1988 Kleber HD. Cocaine abuse: historical, epidemiological, and psychological perspectives. The Journal of Clinical Psychiatry. 49: 3-6. PMID 3257486  0.36
1988 Kosten TR, Kleber HD. Differential diagnosis of psychiatric comorbidity in substance abusers. Journal of Substance Abuse Treatment. 5: 201-6. PMID 3216436 DOI: 10.1016/0740-5472(88)90042-6  0.36
1988 Kosten TR, Kleber HD. Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome? The American Journal of Drug and Alcohol Abuse. 14: 335-46. PMID 3055940 DOI: 10.3109/00952998809001555  0.36
1988 Gawin FH, Kleber HD. Evolving conceptualizations of cocaine dependence. The Yale Journal of Biology and Medicine. 61: 123-36. PMID 3043925  0.36
1987 Kosten TR, Rounsaville BJ, Kleber HD. A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Archives of General Psychiatry. 44: 281-4. PMID 3827521 DOI: 10.1001/archpsyc.1987.01800150101012  0.36
1987 Kosten TR, Rounsaville BJ, Kleber HD. Multidimensionality and prediction of treatment outcome in opioid addicts: 2.5-year follow-up. Comprehensive Psychiatry. 28: 3-13. PMID 3802797 DOI: 10.1016/0010-440X(87)90038-1  0.36
1987 Kosten TR, Jalali B, Steidl JH, Kleber HD. Relationship of marital structure and interactions to opiate abuse relapse. The American Journal of Drug and Alcohol Abuse. 13: 387-99. PMID 3687898 DOI: 10.3109/00952998709001523  0.36
1987 Rounsaville BJ, Kosten TR, Kleber HD. The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study. The American Journal of Drug and Alcohol Abuse. 13: 213-29. PMID 3687888 DOI: 10.3109/00952998709001511  0.36
1987 Kosten TR, Rounsaville BJ, Kleber HD. Predictors of 2.5-year outcome in opioid addicts: pretreatment source of income. The American Journal of Drug and Alcohol Abuse. 13: 19-32. PMID 3687883 DOI: 10.3109/00952998709001498  0.36
1987 Kleber HD, Topazian M, Gaspari J, Riordan CE, Kosten T. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. The American Journal of Drug and Alcohol Abuse. 13: 1-17. PMID 3687878 DOI: 10.3109/00952998709001497  0.36
1987 Kleber HD, Gawin FH. The Physiology of Cocaine Craving and 'Crashing'-Reply Archives of General Psychiatry. 44: 299-300. DOI: 10.1001/archpsyc.1987.01800150123019  0.36
1986 Kosten TR, Kreek MJ, Ragunath J, Kleber HD. Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts. Biological Psychiatry. 21: 217-20. PMID 3947698 DOI: 10.1016/0006-3223(86)90150-2  0.36
1986 Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Archives of General Psychiatry. 43: 107-13. PMID 3947206 DOI: 10.1001/archpsyc.1986.01800020013003  0.36
1986 D'Aquila R, Williams AB, Kleber HD, Williams AE. Prevalence of HTLV-III infection among New Haven, Connecticut, parenteral drug abusers in 1982-1983 New England Journal of Medicine. 314: 117-118. PMID 3941684  0.36
1986 Kosten TR, Rounsaville BJ, Kleber HD. A 2.5 year follow-up of treatment retention and reentry among opioid addicts Journal of Substance Abuse Treatment. 3: 181-189. PMID 3806731 DOI: 10.1016/0740-5472(86)90019-X  0.36
1986 Kosten TR, Gawin FH, Rounsaville BJ, Kleber HD. Cocaine abuse among opioid addicts: Demographic and diagnostic factors in treatment American Journal of Drug and Alcohol Abuse. 12: 1-16. PMID 3788892 DOI: 10.3109/00952998609083739  0.36
1986 Rounsaville BJ, Kosten TR, Kleber HD. Long-term changes in current psychiatric diagnoses of treated opiate addicts. Comprehensive Psychiatry. 27: 480-98. PMID 3757496 DOI: 10.1016/0010-440X(86)90036-2  0.36
1986 Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Archives of General Psychiatry. 43: 739-45. PMID 3729668 DOI: 10.1001/archpsyc.1986.01800080025004  0.36
1986 Kosten TR, Rounsaville BJ, Kleber HD. A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Archives of General Psychiatry. 43: 733-8. PMID 3729667 DOI: 10.1001/archpsyc.1986.01800080019003  0.36
1986 Kosten TR, Hogan I, Jalali B, Steidl J, Kleber HD. The effect of multiple family therapy on addict family functioning: A pilot study Advances in Alcohol and Substance Abuse. 5: 51-62. PMID 3728193 DOI: 10.1300/J251v05n03_04  0.36
1986 Charney DS, Heninger GR, Kleber HD. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. The American Journal of Psychiatry. 143: 831-7. PMID 3717421  0.36
1986 Rounsaville BJ, Kosten TR, Weissmann MM, Kleber HD. A 2.5-year follow-up of short-term interpersonal psychotherapy in methadone-maintained opiate addicts. Comprehensive Psychiatry. 27: 201-10. PMID 3709134 DOI: 10.1016/0010-440X(86)90041-6  0.36
1986 Gawin FH, Byck R, Kleber HD. Desipramine augmentation of cocaine abstinence: initial results Clinical Neuropharmacology. 9: 202-204. PMID 3567940  0.36
1986 Kosten TR, Kreek MJ, Ragunath J, Kleber HD. Chronic naltrexone effect on cortisol Nida Research Monograph Series. 362-365. PMID 3092091  0.36
1986 Kosten TR, Gawin FH, Rounsaville BJ, Kleber HD. Abuse of cocaine with opioids: Psychological aspects of treatment Nida Research Monograph Series. 278-282. PMID 3092078  0.36
1986 Kosten TR, Kreek MJ, Ragunath J, Kleber HD. A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts. Life Sciences. 39: 55-9. PMID 2941636 DOI: 10.1016/0024-3205(86)90437-6  0.36
1985 Kosten TR, Rounsaville BJ, Kleber HD. Ethnic and gender differences among opiate addicts International Journal of the Addictions. 20: 1143-1162. PMID 4077316 DOI: 10.3109/10826088509056356  0.36
1985 Gawin FH, Kleber HD. Neuroendocrine findings in chronic cocaine abusers: A preliminary report British Journal of Psychiatry. 147: 569-573. PMID 4075057  0.36
1985 Rounsaville BJ, Kleber HD. Untreated Opiate Addicts: How Do They Differ From Those Seeking Treatment? Archives of General Psychiatry. 42: 1072-1077. PMID 4051685 DOI: 10.1001/archpsyc.1985.01790340050008  0.36
1985 Kosten TR, Rounsaville BJ, Kleber HD. Parental alcoholism in opioid addicts Journal of Nervous and Mental Disease. 173: 461-469. PMID 4020363  0.36
1985 Kleber HD, Kosten TR. Use of clonidine for dysmenorrhea in four patients Psychosomatics. 26: 539-546. PMID 4011821  0.36
1985 Kleber HD, Riordan CE, Rounsaville B, Kosten T, Charney D, Gaspari J, Hogan I, O'Connor C. Clonidine in outpatient detoxification from methadone maintenance. Archives of General Psychiatry. 42: 391-4. PMID 3977557 DOI: 10.1001/archpsyc.1985.01790270081009  0.36
1985 Gawin FH, Kleber HD. Cocaine use in a treatment: Population: patterns and diagnostic distinctions Nida Research Monograph Series. 182-192. PMID 3932877  0.36
1985 Kleber HD. Treatment of narcotic addicts Psychiatric Medicine. 3: 389-418. PMID 3916682  0.36
1985 Rounsaville BJ, Kleber HD. Psychotherapy/counseling for opiate addicts: Strategies for use in different treatment settings International Journal of the Addictions. 20: 869-896. PMID 3908340 DOI: 10.3109/10826088509047757  0.36
1985 Kosten TR, Rounsaville BJ, Kleber HD. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts American Journal of Drug and Alcohol Abuse. 11: 1-10. PMID 3904410 DOI: 10.3109/00952998509016845  0.36
1985 Kleber HD, Kosten TR, Gaspari J, Topazian M. Nontolerance to the opioid antagonism of naltrexone Biological Psychiatry. 20: 66-72. PMID 2981129 DOI: 10.1016/0006-3223(85)90136-2  0.36
1985 Kleber HD. The Use of Psychotropic Drags in the Treatment of Compulsive Opiate Abusers: The Rationale for Their Use Advances in Alcohol and Substance Abuse. 5: 103-119. PMID 2870623 DOI: 10.1300/J251v05n01_08  0.36
1985 Kleber HD. Brief effective treatment strategies: Pharmacological therapy for opiate addicts Nida Research Monograph Series. 83-99. PMID 2863755  0.36
1985 Kosten TR, Hogan I, Jalali B, Kleber HD. Fatherhood as a precipitant of drug abuse relapse International Journal of Family Psychiatry. 6: 265-272.  0.36
1984 Blatt SJ, Berman W, Bloom-Feshbach S, Sugarman A, Wilber C, Kleber HD. Psychological assessment of psychopathology in opiate addicts. The Journal of Nervous and Mental Disease. 172: 156-65. PMID 6699631  0.36
1984 Hoder EL, Leckman JF, Poulsen J, Caruso KA, Ehrenkranz RA, Kleber HD, Cohen DJ. Clonidine treatment of neonatal narcotic abstinence syndrome Psychiatry Research. 13: 243-251. PMID 6597462 DOI: 10.1016/0165-1781(84)90039-8  0.36
1984 Kleber HD. The impaired physician: Changes from the traditional view Journal of Substance Abuse Treatment. 1: 137-140. PMID 6536757 DOI: 10.1016/0740-5472(84)90039-4  0.36
1984 Khantzian EJ, Gawin F, Kleber HD, Riordan CE. Methylphenidate (Ritalin) treatment of cocaine dependence--a preliminary report. Journal of Substance Abuse Treatment. 1: 107-12. PMID 6536756 DOI: 10.1016/0740-5472(84)90033-3  0.36
1984 Kleber HD. Is there a need for "professional psychotherapy" in methadone programs? Journal of Substance Abuse Treatment. 1: 73-76. PMID 6535843 DOI: 10.1016/0740-5472(84)90058-8  0.36
1984 Kosten TR, Rounsaville BJ, Kleber HD. Relationship of depression to clonidine detoxification of opiate addicts Comprehensive Psychiatry. 25: 503-508. PMID 6488761 DOI: 10.1016/0010-440X(84)90049-X  0.36
1984 Charney DS, Redmond DE, Galloway MP, Kleber HD, Heninger GR, Murberg M, Roth RH. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity. Life Sciences. 35: 1263-72. PMID 6482651 DOI: 10.1016/0024-3205(84)90097-3  0.36
1984 Kleber HD, Kosten TR. Naltrexone induction: Psychologic and pharmacologic strategies Journal of Clinical Psychiatry. 45: 29-38. PMID 6469934  0.36
1984 Kleber HD, Gawin FH. Cocaine abuse: a review of current and experimental treatments Nida Research Monograph Series. 111-129. PMID 6440022  0.36
1984 Kleber HD, Gawin FH. The spectrum of cocaine abuse and its treatment Journal of Clinical Psychiatry. 45: 18-23. PMID 6438067  0.36
1984 Gawin FH, Kleber HD. Cocaine Abuse Treatment: Open Pilot Trial With Desipramine and Lithium Carbonate Archives of General Psychiatry. 41: 903-909. PMID 6431939 DOI: 10.1001/archpsyc.1984.01790200085011  0.36
1984 Kosten TR, Kleber HD. Naltrexone induced appetite suppression and weight loss International Journal of Psychiatry in Medicine. 14: 153-155.  0.36
1983 Murphy SL, Rounsaville BJ, Eyre S, Kleber HD. Suicide attempts in treated opiate addicts. Comprehensive Psychiatry. 24: 79-89. PMID 6851511 DOI: 10.1016/0010-440X(83)90053-6  0.36
1983 Rounsaville BJ, Weissman MM, Wilber C, Kleber HD. Identifying alcoholism in treated opiate addicts American Journal of Psychiatry. 140: 764-766. PMID 6846637  0.36
1983 Kosten TR, Rounsaville BJ, Kleber HD. Relationship of depression to psychosocial stressors in heroin addicts Journal of Nervous and Mental Disease. 171: 97-104. PMID 6822825  0.36
1983 Kosten TR, Rounsaville BJ, Merikangas KR, Prusoff BA, Kleber HD. The relationship of the Maudsley Personality Inventory to depression in addicts Comprehensive Psychiatry. 24: 535-542. PMID 6653096 DOI: 10.1016/0010-440X(83)90021-4  0.36
1983 Kosten TR, Jalali B, Hogan I, Kleber HD. Family denial as a prognostic factor in opiate addict treatment outcome Journal of Nervous and Mental Disease. 171: 611-616. PMID 6619824  0.36
1983 Kosten TR, Rounsaville BJ, Kleber HD. Concurrent validity of the addiction severity index Journal of Nervous and Mental Disease. 171: 606-610. PMID 6619823  0.36
1983 Kleber HD, Weissman MM, Rounsaville BJ, Wilber CH, Prusoff BA, Riordan CE. Imipramine as treatment for depression in addicts. Archives of General Psychiatry. 40: 649-53. PMID 6342564 DOI: 10.1001/archpsyc.1983.04390010059007  0.36
1983 Rounsaville BJ, Glazer W, Wilber CH, Weissman MM, Kleber HD. Short-term Interpersonal Psychotherapy in Methadone-Maintained Opiate Addicts Archives of General Psychiatry. 40: 629-636. PMID 6342563 DOI: 10.1001/archpsyc.1983.04390010039005  0.36
1983 Rounsaville BJ, Eyre SL, Weissman MM, Kleber HD. The antisocial opiate addict Advances in Alcohol and Substance Abuse. 2: 29-42. DOI: 10.1300/J251v02n04_03  0.36
1982 Kosten TR, Jalali B, Kleber HD. Complementary marital roles of male heroin addicts: Evolution and intervention tactics American Journal of Drug and Alcohol Abuse. 9: 155-169. PMID 7171079 DOI: 10.3109/00952998209002619  0.36
1982 Wurzman I, Rounsaville BJ, Kleber HD. Cultural values of Puerto Rican opiate addicts: An exploratory study American Journal of Drug and Alcohol Abuse. 9: 141-153. PMID 7171078 DOI: 10.3109/00952998209002618  0.36
1982 Kosten TR, Rounsaville BJ, Kleber HD. DSM-III personality disorders in opiate addicts Comprehensive Psychiatry. 23: 572-581. PMID 7160176 DOI: 10.1016/0010-440X(82)90050-5  0.36
1982 Rounsaville BJ, Weissman MM, Wilber CH, Kleber HD. Pathways to opiate addiction: An evaluation of differing antecedents British Journal of Psychiatry. 141: 437-446. PMID 7150879  0.36
1982 Rounsaville BJ, Tierney T, Crits-Christoph K, Weissman MM, Kleber HD. Predictors of outcome in treatment of opiate addicts: Evidence for the multidimensional nature of addicts' problems Comprehensive Psychiatry. 23: 462-478. PMID 7140263 DOI: 10.1016/0010-440X(82)90160-2  0.36
1982 Charney DS, Riordan CE, Kleber HD, Murburg M, Braverman P, Sternberg DE, Heninger GR, Redmond DE. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy. Archives of General Psychiatry. 39: 1327-32. PMID 7138234 DOI: 10.1001/archpsyc.1982.04290110077013  0.36
1982 Eyre SL, Rounsaville BJ, Kleber HD. History of childhood hyperactivity in a clinic population of opiate addicts Journal of Nervous and Mental Disease. 170: 522-529. PMID 7108500  0.36
1982 Rounsaville BJ, Weissman MM, Kleber HD. The significance of alcoholism in treated opiate addicts Journal of Nervous and Mental Disease. 170: 479-488. PMID 7097265  0.36
1982 Uhde TW, Redmond DE, Kleber HD. Psychosis in the opioid addicted patient: Assessment and treatment Journal of Clinical Psychiatry. 43: 240-247. PMID 7085579  0.36
1982 Wilber CH, Rounsaville BJ, Sugarman A, Casey JB, Kleber HD. Ego development in opiate addicts. An application of Loevinger's stage model. The Journal of Nervous and Mental Disease. 170: 202-8. PMID 7062006  0.36
1982 Kleber HD, Riordan CE. The treatment of narcotic withdrawal: a historical review. The Journal of Clinical Psychiatry. 43: 30-4. PMID 7045089  0.36
1982 Kleber HD. The interaction of a treatment program using opiates for mental illness and an addiction treatment program Annals of the New York Academy of Sciences. 173-177. PMID 6961854  0.36
1982 Gold MS, Pottash AC, Extein I, Martin D, Kleber HD. Methadone-induced endorphin dysfunction in addicts Nida Research Monograph. 41: 476-482. PMID 6289119  0.36
1982 Kosten TR, Astrachan BM, Riordan CE, Kleber HD. The organization of a methadone maintenance program Journal of Drug Issues. 12: 333-342. DOI: 10.1177/002204268201200402  0.36
1981 Rounsaville BJ, Cacciola J, Weissman MM, Kleber HD. Diagnostic concordance in a follow-up study of opiate addicts Journal of Psychiatric Research. 16: 191-201. PMID 7346631 DOI: 10.1016/0022-3956(81)90005-4  0.36
1981 Gold MS, Pottash AL, Extein I, Finn LB, Kleber HD. Clonidine in opiate withdrawal Current Psychiatric Therapies. 20: 285-291. PMID 7326972  0.36
1981 Anton RF, Hogan I, Jalali B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug and Alcohol Dependence. 8: 157-68. PMID 7318681 DOI: 10.1016/0376-8716(81)90110-1  0.36
1981 Charney DS, Sternberg DE, Kleber HD, Heninger GR, Redmond DE. The Clinical use of Clonidine in Abrupt Withdrawal from Methadone: Effects on Blood Prennssure and Specific Signs and Symptoms Archives of General Psychiatry. 38: 1273-1277. PMID 7305608 DOI: 10.1001/archpsyc.1981.01780360089010  0.36
1981 Rounsaville BJ, Kleber HD, Wilber C, Rosenberger D, Rosenberger P. Comparison of opiate addicts' reports of psychiatric history with reports of significant-other informants American Journal of Drug and Alcohol Abuse. 8: 51-69. PMID 7304512 DOI: 10.3109/00952998109016918  0.36
1981 Rounsaville BJ, Novelly RA, Kleber HD, Jones C. Neuropsychological impairment in opiate addicts: Risk factors Annals of the New York Academy of Sciences. 79-90. PMID 6942714  0.36
1981 Gold MS, Pottash ALC, Extein I, Kleber HD. Dopamine and serum prolactin in methadone withdrawal Nida Research Monograph Series. 367-372. PMID 6783947  0.36
1981 Gold MS, Kleber HD. Clinical utility of clonidine in opiate withdrawal: a study of 100 patients Progress in Clinical and Biological Research. 71: 299-306. PMID 6276899  0.36
1981 Gold MS, Pottash AC, Extein IL, Kleber HD. Neuroanatomical sites of action of clonidine in opiate withdrawal: the locus coeruleus connection Progress in Clinical and Biological Research. 71: 285-298. PMID 6276897  0.36
1981 Gold MS, Pottash ALC, Extein I, Martin DA, Finn LB, Sweeney DR, Kleber HD. Evidence for an endorphin dysfunction in methadone addicts: Lack of ACTH response to naloxone Drug and Alcohol Dependence. 8: 257-262. PMID 6276118 DOI: 10.1016/0376-8716(81)90069-7  0.36
1980 Charney DS, Kleber HD. Iatrogenic opiate addiction: Successful detoxification with clonidine American Journal of Psychiatry. 137: 989-990. PMID 7416311  0.36
1980 Gold MS, Pottash ALC, Sweeney DR, Davies RK, Kleber HD. Clonidine decreases opiate withdrawal-related anxiety: possible opiate noradrenergic interaction in anxiety and panic Substance and Alcohol Actions/Misuse. 1: 239-246. PMID 7302782  0.36
1980 Kleber HD, Gold MS, Riordan CE. The use of clonidine in detoxification from opiates. Bulletin On Narcotics. 32: 1-10. PMID 6907020  0.36
1980 Gold MS, Pottash ALC, Extein I, Kleber HD. Anti-endorphin effects of methadone Lancet. 2: 972-973. PMID 6107608  0.36
1980 Gold MS, Pottash ALC, Kleber HD, Extein I. Opiate withdrawal, clonidine and serum PRL: Evidence against a dopamine hypothesis Neuroendocrinology Letters. 2: 351-356.  0.36
Show low-probability matches.